[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370588-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370588-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrating-bulk-rna-seq-and-scrna-seq-analyses-with-machine-learning-to-predict-platinum-response-and-prognosis-in-ovarian-cancer","Integrating bulk RNA-seq and scRNA-seq analyses with machine learning to predict platinum response and prognosis in ovarian cancer","","Platinum-based therapy is central to standard ovarian cancer treatment, yet reliable clinical biomarkers for platinum response remain difficult to identify. Single-cell transcriptomic analysis was used to isolate platinum-sensitive and platinum-resistant cancer cells and to detect differential genes linked to resistance-associated biology. Enrichment results highlighted autophagy, cell-cycle regulation, and DNA damage repair pathways. Seven machine-learning models were evaluated, and random forest yielded the strongest predictive performance, leading to the GPPS signature that also supports prognosis estimation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-bulk-rna-seq-and-scrna-seq-analyses-with-machine-learning-to-predict-platinum-response-and-prognosis-in-ovarian-cancer/370588/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-bulk-rna-seq-and-scrna-seq-analyses-with-machine-learning-to-predict-platinum-response-and-prognosis-in-ovarian-cancer/370588.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are biomarkers for platinum response in ovarian cancer difficult to identify clinically?","Question",{"text":63,"@type":64},"Despite decades of research, dependable predictive biomarkers have not been reliably established for routine clinical use.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were platinum-sensitive and platinum-resistant cancer cells analyzed in this study?",{"text":68,"@type":64},"Cancer cells were isolated from single-cell transcriptomic data for platinum-sensitive and platinum-resistant patients, followed by differential gene analysis and pathway enrichment.",{"name":70,"@type":61,"acceptedAnswer":71},"Which machine-learning model performed best, and what genes define it?",{"text":72,"@type":64},"The random forest model performed best using five genes: PAX2, TFPI2, APOA1, ADIRF, and CRISP3, forming the GPPS signature.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370588,1790298065,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrating bulk RNA-seq and scRNA-seq analyses with machine learning to predict platinum response and prognosis in ovarian cancer  \nTingting Gao1,2, Peng Zhao3 & Suxia Han1􀀍  \nPlatinum-based therapy is an integral part of the standard treatment for ovarian cancer. However, despite extensive research spanning several decades, the identification of dependable predictive biomarkers for platinum response in clinical practice has proven to be a formidable challenge. Recently, the development of single-cell technology has enabled more precise investigations into the heterogeneity of cancer. In this study, we isolated cancer cells from the single-cell transcriptomic data of platinum-sensitive and platinum-resistant patients with ovarian cancer. Differential gene analysis of platinum-sensitive and platinum-resistant cancer cells revealed that several of the differentially expressed genes had previously been reported in other studies to be associated with platinum resistant. Gene set enrichment analysis revealed the up-regulation of pathways involved in processes such as autophagy, cell cycle regulation, and DNA damage repair, which are known to promote platinum resistance in ovarian cancer. Based on these findings, we hypothesized that these differentially expressed genes could be used to predict the response of ovarian cancer patients to platinum-based chemotherapy. To validate this hypothesis, we explored 7 different machine learning models for predicting platinum chemotherapy response at varying feature gene counts. Ultimately, the random forest model performed the best, with 5 genes (PAX2, TFPI2, APOA1, ADIRF and CRISP3) and achieve an AUC of 0.993 in test cohort and 0.989 in GSE63885 independent validation cohorts. We named this model GPPS (Genes to Predict Platinum response Signature) . Furthermore, we discovered that the GPPS model can also predict patient prognosis.  \nKeywords Single-cell RNA sequence, Heterogeneity, Ovarian cancer, Platinum chemotherapy, Machine learning, Prognosis  \nOvarian cancer is the most fatal type of gynecological malignancy, with a survival rate of fewer than 50% after a 5-year period1. Platinum-based therapy is an integral part of the standard treatment for ovarian cancer2. The use of platinum-based chemotherapy in ovarian cancer patients can lead to an increase of more than 10% in their 10-year survival rate, while also doubling the objective response rate, according to previous studies3. However, the majority of ovarian cancer patients will eventually develop platinum resistance, leading to an almost inevitable and fatal refractory disease4. Anti-angiogenesis therapies have emerged as a critical strategy in the treatment of ovarian cancer, targeting the vascular endothelial growth factor (VEGF) pathway to inhibit tumor-associated angiogenesis. Angiogenesis, the formation of new blood vessels, is a fundamental process for tumor growth and metastasis. In ovarian cancer, VEGF plays a pivotal role in promoting tumor vascularization, increasing vascular permeability, and facilitating peritoneal dissemination5 By blocking VEGF signaling, antiangiogenic agents can reduce tumor vascularization, normalize abnormal vasculature, and enhance the efficacy of chemotherapy by improving drug delivery. Bevacizumab, a monoclonal antibody targeting VEGF-A, was the first anti-angiogenic agent approved for ovarian cancer treatment. Clinical trials such as GOG-218 and ICON7 demonstrated that the addition of bevacizumab to standard chemotherapy significantly prolonged progression-  \n1Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China.  \n2Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Air Force Medical University, Xi’an 710038, China. 3Oncology Department of Xi’an Daxing Hospital, Xi’an, China. 􀀍 email: [shan87@xjtu.edu.cn](shan87@xjtu.edu.cn)  \n[www. n","cbCair2aXS3mSRM7","https://ap.wps.com/l/cbCair2aXS3mSRM7","pdf",3898331,12,"English","# Background and clinical challenge\n# Single-cell analysis and discovery of resistance-associated genes\n# Machine-learning model development and validation\n## GPPS signature and predictive performance\n# Extension to prognosis prediction","[{\"question\":\"Why are biomarkers for platinum response in ovarian cancer difficult to identify clinically?\",\"answer\":\"Despite decades of research, dependable predictive biomarkers have not been reliably established for routine clinical use.\"},{\"question\":\"How were platinum-sensitive and platinum-resistant cancer cells analyzed in this study?\",\"answer\":\"Cancer cells were isolated from single-cell transcriptomic data for platinum-sensitive and platinum-resistant patients, followed by differential gene analysis and pathway enrichment.\"},{\"question\":\"Which machine-learning model performed best, and what genes define it?\",\"answer\":\"The random forest model performed best using five genes: PAX2, TFPI2, APOA1, ADIRF, and CRISP3, forming the GPPS signature.\"}]","Integrating bulk RNA-seq and scRNA-seq analyses with machine learning to predict platinum response and prognosis in ovarian cancer | PDF",1790189367,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67fa1270a1e1bc181e16dc9f5108885a.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd28cb3cd700a1154c14036ac9319038.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cd8b9efea60a0c9a6d22a849937bc19.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c4057741b6b65f633ec2b7a07718a91.webp",980,1287]